More on MRK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Dividends
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/28/15)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Merck (NY:MRK)
Delayed: 57.10 -0.5 (0.87%)
Trade Now!
Previous Close $57.60    52 Week High $63.62 
Open $57.83    52 Week Low $52.49 
Day High $58.03    P/E 38.84 
Day Low $56.88    EPS $1.47 
Volume 10,369,015       

Friends, Peers and Foes (?): CBST, NLNK, IDIX, GILD, MKGAY (more...)

Apr 27, 2015 03:05 PM Trading Radar for 4/28: Ford (F), Aetna (AET), Twitter (TWTR), GoPro (GPRO), Panera Bread (PNRA) Report
Apr 24, 2015 01:00 AM Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across Broad Range of Patients with Chronic Hepatitis C Virus Infection
Apr 23, 2015 07:00 AM EMD Millipore Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs
Apr 23, 2015 03:30 AM Merck Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Apr 22, 2015 05:28 PM Market Wrap: Q1 Earnings Season Gets into Swing; Google Aims to Challenge Wireless Carriers; Existing Home Sales Outpaced in March
Apr 22, 2015 08:09 AM Organovo (ONVO) Enters Multi-Year Research Collaboration Agreement with Merck (MRK)
Apr 22, 2015 08:02 AM Tim McGraw, Merck and the American Diabetes Association Challenge Americans with Type 2 Diabetes to Get to Their A1C Goal
Apr 21, 2015 08:30 AM Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress
Apr 20, 2015 08:02 AM TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination with KEYTRUDA® (pembrolizumab) in Solid Tumors
Apr 20, 2015 08:02 AM TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid Tumors
View All Articles